DRDO: DCGI approves anti-Covid drug developed by DRDO for emergency use; new drug helps sustain oxygen level in body, says DRDO scientist – The Economic Times Video

An anti-Covid oral drug developed by the DRDO has been accredited by the Medication Controller Basic of India (DCGI) for emergency use as an adjunct remedy in reasonable to extreme coronavirus sufferers, the defence ministry stated on Saturday. ET NOW caught up with the DRDO scientist Dr. Anant Narayan Bhatt and tried to grasp how the drug can be utilized within the remedy of hospitalised Covid-19 sufferers.

Scroll to Top